<DOC>
	<DOC>NCT01636193</DOC>
	<brief_summary>This study aims to assess the safety of Oral Rotarix® under clinical practice; and collect information regarding typical symptoms of intussusceptions and bloody stool in Japan.</brief_summary>
	<brief_title>Drug Use Investigation for ROTARIX®</brief_title>
	<detailed_description>This is non-interventional study conducted in one group received Oral Rotarix®. This surveillance is abbreviated as SMILER (Surveillance and Monitoring In Living clinical Experience for Rotarix).</detailed_description>
	<mesh_term>Rotavirus Infections</mesh_term>
	<criteria>• Infants who receive Rotarix for the first time to prevent rotavirus gastroenteritis, an indication of Rotarix, will be included in the investigation. • All infants included in the special drug use investigation of Oral Rotarix will be excluded.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Rotavirus</keyword>
	<keyword>Rotarix</keyword>
	<keyword>Drug Use Investigation</keyword>
	<keyword>Safety</keyword>
</DOC>